Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 301 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 2 (15%) | |
| Discontinued: | 11 (85%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MANERIX | 300MG | TABLET | Resolved | 2018-11-09 | 2019-02-12 | 66586 |
| MANERIX | 300MG | TABLET | Resolved | 2020-02-14 | 2021-04-01 | 106249 |
| ROFACT | 300MG | CAPSULE | Resolved | 2017-03-13 | 2017-04-12 | 1621 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2018-05-11 | 2018-07-09 | 49062 |
| ROFACT | 300MG | CAPSULE | Resolved | 2018-10-29 | 2019-08-01 | 65751 |
| ROFACT | 300MG | CAPSULE | Resolved | 2019-09-06 | 2020-03-18 | 93246 |
| ROFACT | 300MG | CAPSULE | Resolved | 2022-12-02 | 2023-02-24 | 176953 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2023-03-13 | 2023-03-27 | 186883 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2024-02-22 | 2024-02-22 | 220173 |
| ROFACT | 300MG | CAPSULE | Resolved | 2024-03-18 | 2024-04-17 | 222584 |
| WELLBUTRIN XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-09-10 | 2018-12-21 | 61164 |
| WELLBUTRIN XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-29 | 2018-12-21 | 68111 |
| WELLBUTRIN XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-10 | 2019-04-03 | 71883 |
| WELLBUTRIN XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-20 | 2022-09-23 | 165044 |
| RALIVIA | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-15 | 2017-09-25 | 22158 |
| RALIVIA | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-07 | 2022-06-02 | 158239 |
| ETIBI | 400MG | TABLET | Resolved | 2019-06-07 | 2020-02-28 | 85831 |
| ETIBI | 400MG | TABLET | Avoided shortage | 2020-03-05 | 2020-03-05 | 107813 |
| ETIBI | 400MG | TABLET | Resolved | 2020-03-12 | 2020-06-16 | 108558 |
| ETIBI | 400MG | TABLET | Avoided shortage | 2023-10-19 | 2023-11-09 | 207367 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| DELATESTRYL | 200MG | SOLUTION | To be discontinued | 2024-03-11 | 2024-03-11 | 221772 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
Showing 1 to 13 of 13